{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:10Z","timestamp":1787026450101,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cutaneous melanoma, characterized by the malignant proliferation of melanocytes, exhibits high invasiveness and metastatic potential. Thus, identifying novel prognostic biomarkers and therapeutic targets is essential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized single-cell RNA sequencing data (GSE215120) from the Gene Expression Omnibus (GEO) database, preprocessing it with the Seurat package. Dimensionality reduction and clustering were executed through Principal Component Analysis (PCA) and Uniform Manifold Approximation and Projection (UMAP). Cell types were annotated based on known marker genes, and the AUCell algorithm assessed the enrichment of deubiquitination-related genes. Cells were categorized into DUB_high and DUB_low groups based on AUCell scores, followed by differential expression analysis. Importantly, we constructed a robust prognostic model utilizing various genes, which was evaluated in the TCGA cohort and an external validation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our prognostic model, developed using Random Survival Forest (RSF) and Ridge Regression methods, demonstrated excellent predictive performance, evidenced by high C-index and AUC values across multiple cohorts. Furthermore, analyses of immune cell infiltration and tumor microenvironment scores revealed significant differences in immune cell distribution and microenvironment characteristics between high-risk and low-risk groups. Functional experiments indicated that TBC1D16 significantly impacts the migration and proliferation of melanoma cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the critical role of deubiquitination in melanoma and presents a novel prognostic model that effectively stratifies patient risk. The model\u2019s strong predictive ability enhances clinical decision-making and provides a framework for future studies on the therapeutic potential of deubiquitination mechanisms in melanoma progression. Further validation and exploration of this model\u2019s applicability in clinical settings are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2024.1509049","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T01:30:30Z","timestamp":1733362230000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the impact of deubiquitination on melanoma prognosis through single-cell RNA sequencing"],"prefix":"10.3389","volume":"15","author":[{"given":"Su","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5802\/crbiol.63","article-title":"Cutaneous and uveal melanoma: two different cancers in therapeutic needs","volume":"344","author":"Bertolotto","year":"2021","journal-title":"C R. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"20429","DOI":"10.1073\/pnas.0905139106","article-title":"Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival","volume":"106","author":"Bogunovic","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"60940","DOI":"10.18632\/oncotarget.10902","article-title":"Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair","volume":"7","author":"Budden","year":"2016","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1089\/jwh.2021.0223","article-title":"Sex differences in cutaneous melanoma: incidence, clinicopathological profile, survival, and costs","volume":"31","author":"Buja","year":"2022","journal-title":"J. Womens Health (Larchmt)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/14737159.2020.1696194","article-title":"Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma","volume":"20","author":"Carpi","year":"2020","journal-title":"Expert Rev. Mol. Diagn"},{"key":"B8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","article-title":"Ubiquitination in the regulation of inflammatory cell death and cancer","volume":"28","author":"Cockram","year":"2021","journal-title":"Cell Death Differ."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.21873\/anticanres.16010","article-title":"Cutaneous melanoma: sheep in wolves clothing?","volume":"42","author":"DE Gruijl","year":"2022","journal-title":"Anticancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000488708","article-title":"Metastatic cutaneous melanoma presenting with choroidal metastasis simulating primary uveal melanoma","volume":"5","author":"Everett","year":"2019","journal-title":"Ocul. Oncol. Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/jcmm.16243","article-title":"The regulation of NONO by USP11 via deubiquitination is linked to the proliferation of melanoma cells","volume":"25","author":"Feng","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: Update 2022","volume":"170","author":"Garbe","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"111396","DOI":"10.1016\/j.celrep.2022.111396","article-title":"Targeting the USP7\/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC\/LSD1 inhibitors","volume":"40","author":"Granieri","year":"2022","journal-title":"Cell Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/s41418-022-00971-8","article-title":"Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis","volume":"29","author":"Han","year":"2022","journal-title":"Cell Death Differ."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/2159-8290.CD-23-0352","article-title":"Biomarker-driven personalization of neoadjuvant immunotherapy in melanoma","volume":"13","author":"Hoeijmakers","year":"2023","journal-title":"Cancer Discov."},{"key":"B16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.ymthe.2020.12.032","article-title":"Emerging role of ubiquitination in the regulation of PD-1\/PD-L1 in cancer immunotherapy","volume":"29","author":"Hu","year":"2021","journal-title":"Mol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1228200","DOI":"10.3389\/fimmu.2023.1228200","article-title":"Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy","volume":"14","author":"Jiang","year":"2023","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-09-2509","article-title":"Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome","volume":"16","author":"J\u00f6nsson","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/jdv.18701","article-title":"Cutaneous melanoma metastases: clinical and dermoscopic findings","volume":"37","author":"Kostaki","year":"2023","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3892\/ijo.2020.5088","article-title":"Cutaneous melanoma and the immunotherapy revolution (Review)","volume":"57","author":"Leonardi","year":"2020","journal-title":"Int. J. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamadermatol.2020.4616","article-title":"UV exposure and the risk of cutaneous melanoma in skin of color: a systematic review","volume":"157","author":"Lopes","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biocel.2018.06.001","article-title":"Ubiquitination: friend and foe in cancer","volume":"101","author":"Mansour","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B25","first-page":"132","article-title":"Controversies in the diagnosis and treatment of early cutaneous melanoma","volume":"8","author":"Orzan","year":"2015","journal-title":"J. Med. Life."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"103425","DOI":"10.1016\/j.critrevonc.2021.103425","article-title":"Molecular landscape of hereditary melanoma","volume":"164","author":"Ribeiro Moura Brasil Arnaut","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s11912-023-01453-x","article-title":"Mucosal melanoma: epidemiology, clinical features, and treatment","volume":"25","author":"Sergi","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nm.3863","article-title":"Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR","volume":"21","author":"Vizoso","year":"2015","journal-title":"Nat. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41419-020-02760-y","article-title":"Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s10495-024-01960-7","article-title":"Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning","volume":"29","author":"Xiao","year":"2024","journal-title":"Apoptosis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1220108","DOI":"10.3389\/fendo.2023.1220108","article-title":"The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer","volume":"14","author":"Ye","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1038\/s41467-022-34877-3","article-title":"A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/cancers16050908","article-title":"Tumoral C2 regulates the tumor microenvironment by increasing the ratio of M1\/M2 macrophages and tertiary lymphoid structures to improve prognosis in melanoma","volume":"16","author":"Zhang","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1509049\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T03:50:47Z","timestamp":1733457047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1509049\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":34,"alternative-id":["10.3389\/fgene.2024.1509049"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1509049","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"article-number":"1509049"}}